MedPath
NMPA Approval

Benralizumab Injection

国药准字SJ20240040

September 27, 2024

Drug Information

本瑞利珠单抗注射液

凡舒卓

注射剂

单剂量自动注射笔:30 mg(1.0 ml)/支

生物制品

September 27, 2024

August 12, 2029

Company Information

Applicant Company

ASTRAZENECA AB

Karlebyhus, Astraallen, Sodertalje, Stockholm SE 151-85 SWEDEN

Manufacturing Company

ASTRAZENECA AB

Gartunavagen, Sodertalje 152 57 SWEDEN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

本瑞利珠单抗注射液 - NMPA 批准文号 | MedPath